Other
Survival
0
Pipeline Programs↗
5
Active Trials↗
3
Companies Involved↗
Survival is an early-stage landscape with 0 programs across 3 companies. The most active players are AstraZeneca, Quince Therapeutics S.p.A., Kun-Ming Rau.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
31
clinical trials
Completed16 · 52%
Unknown status5 · 16%
Terminated4 · 13%
Not yet recruiting2 · 6%
Recruiting2 · 6%
Withdrawn1 · 3%
Other1 · 3%
Clinical Trials
Trial Activity
31 trials
Evaluation of 5-year Survival and Clinical Outcomes in Patients Undergoing Total Knee Arthroplasty With a Polyethylene Tibial Component
Recruiting·—·Preclinical·NCT07544264·78 enrolled
Heparin Alone vs. Heparin-Aspirin Combo in Free Flap Survival
Not yet recruiting·—·N/A·NCT06512233·126 enrolled
Comparative Analysis of Biotinylated, Irradiated and 51-Chromium Radiolabeled Red Blood Cells for Analysis of Recovery and Survival After Autologous Transfusion
Not yet recruiting·—·Phase 1·NCT07446647·20 enrolled
Red Blood Cell (RBC) Survival Following Transfusion in Infants
Completed·—·Phase 2·NCT00731588·140 enrolled
Optimization of Biotinylation Protocol for Studies of Red Blood Cell Survival and Function After Transfusion
Completed·—·Phase 1·NCT06788080·12 enrolled
Strategies to Improve Islet Survival
Completed·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT00464555·5 enrolled
Page 1 of 3
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)